Take a closer look at London's biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure ...

Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...